Dr. James E. Galvin, MD, MPH

Expert Publications

• Cytotoxic mAb from rheumatic carditis recognizes heart valves and laminin.
• Pasteurella multocida toxin type D serological assay as an alternative to the toxin neutralisation lethality test in mice.
• Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds.
• Detection of aggregates and protein inclusions by staining of tissues.
• Dementia with Lewy bodies.
• Expression profiling and pharmacotherapeutic development in the central nervous system.
• The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
• Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study.
• Verbal and visuospatial deficits in dementia with Lewy bodies.
• Expression profiling in the aging brain: a perspective.
• Neuroanatomical predictors of response to donepezil therapy in patients with dementia.
• The alpha-synuclein mutation E46K promotes aggregation in cultured cells.
• Interaction of alpha-synuclein and dopamine metabolites in the pathogenesis of Parkinson's disease: a case for the selective vulnerability of the substantia nigra.
• Development of a population-based questionnaire to explore psychosocial determinants of screening for memory loss and Alzheimer Disease.

Clinical Trials

• The Dementia Symptom Management at Home Program

Media Releases

Get to know Neurologist Dr. James E. Galvin, who serves patients throughout the State of Florida.

A renowned cognitive neurologist, Dr. Galvin is one of the world’s leading experts in cognitive aging, dementia, and neurodegenerative diseases. He is the Alexandria and Bernard Schoninger Endowed Chair in Memory Disorders, Chief of the Division of Cognitive Neurology, Founding Director of the Comprehensive Center for Brain Health, and Director and Principal Investigator of the Lewy Body Dementia Research Center of Excellence, leading brain health and neurodegenerative disease research and clinical programs. 

Dr. Galvin and his colleagues at the Comprehensive Center for Brain Health (CCBH) employ an innovative collaborative care model to provide world-class clinical care, conduct cutting edge state-of-the-science clinical and translational research in brain health and neurodegenerative disease. CCBH also develops unique training opportunities for students, residents, fellows, staff, and faculty to gain training, knowledge, and expertise in brain health and neurodegenerative diseases and provide structured mentoring opportunities for early-stage investigators on their path to research independence. CCBH also is actively involved in providing educational programming for the lay community. 

Highly educated, Dr. Galvin received his Bachelor of Arts degree in Chemistry from New York University, his Master of Science degree in Nutrition from Rutgers University, his medical degree from the University of Medicine and Dentistry of New Jersey, and his Master of Public Health degree from St. Louis University. He then completed an internship at the Hackensack University Hospital, residencies at Thomas Jefferson University and MCP Hahnemann, and a fellowship in experimental neuropathology and neurodegenerative disease at the University of Pennsylvania.

Prior to his move to Florida, Dr. Galvin served on faculty at Washington University School of Medicine in St Louis, MO and New York University Langone Medical Center in New York, NY. Dr. Galvin currently serves as a Professor of Neurology and Psychiatry & Behavioral Sciences at the University of Miami Miller School of Medicine. A Fellow of the American Neurological Association, he is board-certified in neurology by the American Board of Psychiatry and Neurology. 

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient.

The major focus of Dr. Galvin’s clinical and research career has been to improve the clinical care and quality of life for all older adults from diverse backgrounds and their family caregivers who are dealing with neurodegenerative disorders in order to initiate early intervention, alleviate psychosocial burden on the patient and family, reduce the impact of race, language, culture, and class on the delivery of health services, and improve health outcomes. His current research program focuses on four themes: (1) developing and validating new clinical assessment scales to improve detection of cognitive impairment in multicultural community samples to improve health outcomes; (2) studying the interaction between race, ethnicity, socioeconomic status, and multiple chronic conditions on the risk of cognitive impairment; (3) characterizing the clinical, cognitive, behavioral, and biomarker features of neurodegenerative disorders; and (4) creating novel precision-medicine based interventions based on individual phenotypic, biomarker, and genomic profiles aimed at improving brain health, reducing risk of developing Alzheimer’s disease and related dementias, and testing novel approaches to dementia prevention.

Throughout his extensive line of work, Dr. Galvin has authored over 325 scientific publications and 3 textbooks on healthy brain aging, cognitive health, Alzheimer’s disease, Lewy Body dementia, and related disorders. He has also received over $120 Million in research funding from the National Institutes of Health, Alzheimer’s Association, Michael J Fox Foundation, American Federation for Aging Research, Lewy Body Dementia Association (where he serves on the Board of Directors), Association for Frontotemporal Degeneration, Missouri, New York, and Florida Departments of Health, and numerous private and family foundations. He develops and leads numerous clinical trials investigating new diagnostics and therapeutics for neurodegenerative disease. 

Recommended Articles

• Copperhead Snake Bites: What Does It Look Like?

  Copperhead snake bites are one of the frequently reported snakebites annually. However, they are rarely fatal. Most of the time, snakebites happen when people accidentally step on or touch snakes, which are excellent at blending into their surroundings. When copperhead snakes are disturbed, they...

• Understanding Clinical Depression

  Clinical depression is a serious medical illness that negatively affects how an individual feels, thinks, and how he or she acts. Depression varies from mild to severe, and in certain instances the individual can experience temporary episodes of sadness.Clinical depression is also known as major...

• What Are Cruciferous Vegetables: Health Benefits and Recipes

  IntroductionCabbage, kale, cauliflower, and broccoli have one thing in common--they all belong to the family of cruciferous vegetables. Cruciferous vegetables are loaded with so many nutrients such as fiber, vitamins, and phytonutrients. These nutrients play very important roles when it comes to...

• Anemia Symptoms

  What is anemia?Anemia occurs when there are low levels of red blood cells (RBCs) in the body. Red blood cells are the ones that carry oxygen all over the body. So when a person's RBC count is lower than normal, it means that there is not enough oxygen in the blood, causing symptoms of anemia, such...

• Questions You Should Be Asking Your Doctor

  IntroductionAlthough doctors have the best intentions, it does not always mean that they will perfectly recognize their patient’s greatest need. For this reason, patients also need to take an active role when it comes to communicating with their doctor.One of the best ways to make sure that...

• What Is Pyrexia: Causes, Symptoms, and Treatment

  Introduction Pyrexia is the medical term for fever, in which the human body temperature rises above the average normal (37 degrees Celsius or 98.6 degrees Fahrenheit). Pyrexia is one of the most common symptoms of numerous medical conditions.There are multiple factors can affect the normal body...